Renowned luminaries in Personalized Medicine
Groundbreaking companies with emerging technologies
More than 1000 peers and patients from around the globe
50 sessions in 3 parallel tracks

CO-HOSTED WITH
STANFORD HEALTH CARE, UCSF, & ORACLE

Patient Experience

With a panel comprised of a precision cancer medicine survivor, an ASCO chief medical officer, a renowned clinical oncologist and president of Medicine & Science at Cancer Treatment Centers of America®, and a chief compliance officer, the real meaning of “patient experience” in today’s unsettling health care environment is uncovered. From genomic testing and targeted, precision cancer therapies to ACA impact and hospital/payer challenges, the convergence of scientific advancement and new treatment options creates a new paradigm.  

SPEAKERS

John E. Steiner, Chief Compliance & Privacy Officer & Associate General Counsel, CTCA

John E. Steiner, Jr. is the Chief Compliance and Privacy Officer and Associate General Counsel for Cancer Treatment Centers of America (CTCA). He is responsible for the design, implementation and administration of the enterprise compliance program. Read Full Bio

Maurie Markman, M.D., President, Medicine & Science, CTCA

Dr. Maurie Markman is the President, Medicine & Science, Cancer Treatment Centers of America, and for more than 25 years has been engaged in clinical research in the area of gynecologic malignancies, with a particular focus on new drug development and exploring novel management strategies in female pelvic cancers. Read Full Bio

Richard L. Schilsky, M.D., FACP, FASCO, Chief Medical Officer, American Society of Clinical Oncology

Dr. Schilsky earned his M.D. at the University of Chicago Pritzker School of Medicine in 1975. Following a residency in Internal Medicine at the University of Texas Southwestern Medical Center and Parkland Memorial Hospital, he received training in Medical Oncology and Clinical Pharmacology at the National Cancer Institute (NCI) from 1977 to 1981. Read Full Bio

Christine Bray, Patient

In 2010, 30 year old Christine Bray was diagnosed with stage I ovarian cancer. Despite having surgery and chemotherapy, she had two more recurrences within the year, causing the cancer to become aggressive. Doctors weren’t expecting her to make it through the summer and were ready to give up. But Christine wasn’t. Read Full Bio

 
Web Analytics